For thirty years, Richard Barker has been one of the U.K.’s healthcare thought leaders. He is the Founder of New Medicine Partners and the Founding Director of the Centre for the Advancement of Sustainable Medical Innovation (CASMI), where he championed the concept of adaptive licensing. With the current U.S. focus on international reference pricing for Medicare Part D & B, Richard’s work in Adaptive Reimbursement is gaining traction as a potential solution to pricing debates that are currently reaching a global crescendo. 

Dr Barker was the Director General of the Association of the British Pharmaceutical Industry (ABPI) for six years between 2004 and 2011, and intimately understands both NHS budget constraints, as well as the need for a vibrant investment ecosystem to make healthcare innovation a reality. Richard is currently Chairman of the Health Innovation Network of South London, and a member of the Celgene board of Directors. He is the former EU head of McKinsey’s Healthcare practice and was also the General Manager of IBM's healthcare business.

For thirty years, Richard Barker has been one of the U.K.’s healthcare thought leaders. He is the Founder of New Medicine Partners and the Founding Director of the Centre for the Advancement of Sustainable Medical Innovation (CASMI), where he championed the concept of adaptive licensing. With the current U.S. focus on international reference pricing for Medicare Part D & B, Richard’s work in Adaptive Reimbursement is gaining traction as a potential solution to pricing debates that are currently reaching a global crescendo. <br><br>Dr Barker was the Director General of the Association of the British Pharmaceutical Industry (ABPI) for six years between 2004 and 2011, and intimately understands both NHS budget constraints, as well as the need for a vibrant investment ecosystem to make healthcare innovation a reality. Richard is currently Chairman of the Health Innovation Network of South London, and a member of the Celgene board of Directors. He is the former EU head of McKinsey’s Healthcare practice and was also the General Manager of IBM's healthcare business.

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

<p>Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.</p>

Duane Schulthess, Managing Director of Vital Tran…

Vital Health Podcast

For thirty years, Richard Barker has been one of …